
Former Neumora CEO to lead Galapagos spinout
Galapagos, a Belgium-based drugmaker, has selected the former head of a once-buzzy neuroscience startup to lead a spinout company that will lean on deals to build its slate of research programs. On Monday, Galapagos’ board of directors appointed Henry …